| 臺大學術典藏 |
2021-01-05T00:56:34Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Chen C.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tien H.-F.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Lee M.-C.; Lai Y.-J.; Jhuang J.-Y.; Tang J.-L.; Hou H.-A.; Chen Y.-K.; Tien H.-F.; Chen Y.-C.; Tsay W.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:33Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Liu C.-Y.; Chen C.-Y.; Lin C.-C.; Lai Y.-J.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:32Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Tseng M.-H.; Lin L.-I.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; SHANG-JU WU; Lin C.-T.; Chen C.-Y.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:32Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
SHANG-JU WU; Tang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Tien H.-F.; Hou H.-A.; Chou W.-C.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Chen C.-Y.; Liu C.-Y.; Lin C.-C.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:31Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Chiang Y.-C.; Tseng M.-H.; Chou W.-C.; Lin C.-C.; Lin T.-Y.; Yao C.-Y.; Hou H.-A.; Li C.-C.; Hsu S.-C.; Chen C.-Y.; Ko B.-S.; Lin C.-T.; Liao X.-W.; SHANG-JU WU; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:28Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Ko B.-S.; Huang S.-Y.; Li C.-C.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:26Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tseng M.-H.; Kuo Y.-Y.; Chen C.-Y.; Chiu Y.-C.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Liao X.-W.; Lin L.-I.; Lin C.-T.; SHANG-JU WU; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:26Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tang J.-L.; Hou H.-A.; Tsai C.-H.; Tien F.-M.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W. |
| 臺大學術典藏 |
2021-01-05T00:56:25Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Chou S.-C.; Liu J.-H.; SHANG-JU WU; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:13:09Z |
Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: A high relapse rate in patients with high initial and peak white blood cell counts during all-trans-retinoic acid treatment
|
HWEI-FANG TIEN; Chen Y.-C.; Shen M.-C.; Lin M.-T.; Wang C.-H.; Lee F.-Y.; Liang Y.-J.; Yao M.; Tang J.-L.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:09Z |
Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-cis retinoic acid
|
Cheng A.-L.; Wang C.-H.; Chang Y.-C.; Liang D.-C.; HWEI-FANG TIEN; Su I.-J.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:06Z |
Clonal disease of natural killer large granular lymphocytes in Taiwan
|
HWEI-FANG TIEN; Chuang S.-M.; Shen M.-C.; Wang C.-H.; Lee F.-Y.U.; Liu M.-C.; Chen Y.-C.; Huang S.-Y.I.; Su I.-J.; Tang J.-L.; Chiang I.-P.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:06Z |
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia
|
Chen Y.-C.; Shen M.-C.; Wang C.-H.; Chung C.-Y.; Yao Y.U.-T.; Chou W.-C.; Kuo T.-L.I.; Huang S.-F.; HWEI-FANG TIEN; Tang J.-L.; Chang C.-S.; Huang S.-Y.I. |
| 臺大學術典藏 |
2021-01-04T12:12:59Z |
Chromosomal abnormalities of 200 Chinese patients with non-Hodgkins's lymphoma in Taiwan: With special reference to T-cell lymphoma
|
Lee F.-Y.; Su I.-J.; Wang C.-C.; Chou W.-C.; Tsay W.; Tang J.-L.; Yao M.; Chen C.-Y.; Liu M.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
|
Huang S.-Y.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Tang J.-L.; Yao M.; Wu S.-J.; Tsay W.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:55Z |
Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
|
HWEI-FANG TIEN; Huang C.-F.; Chen C.-Y.; Huang S.-Y.; Huang K.-C.; Yao M.; Tsay W.; Wu S.-J.; Tang J.-L.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:52Z |
Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia
|
Lin L.-I.; Hou H.-A.; Chou W.-C.; HWEI-FANG TIEN; Lee C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:46Z |
Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
|
Tang J.-L.; Chen B.-B.; Liu C.-Y.; Shih T.T.F.; Hou H.-A.; Yao M.; Huang S.-Y.; Chou W.-C.; Hsu C.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:44Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Chen C.-Y.; Lin C.-W.; Jhuang J.-Y.; Cheng C.-L.; Hou H.-A.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:43Z |
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; Tang J.-L.; Chen C.-Y.; Chou W.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:42Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Li Y.; Kuo Y.-Y.; Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Ko B.-S.; Yao M.; Huang S.-Y.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:41Z |
Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
|
Chen C.-Y.; Chou W.-C.; Tsay W.; Tang J.-L.; Yao M.; Huang S.-Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:39Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; HWEI-FANG TIEN; Tsay W.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:35Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Chou W.-C.; Lin C.-C.; Hou H.-A.; HWEI-FANG TIEN; Chen Y.-C.; Tsay W.; Wu S.-J.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-04T12:12:34Z |
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12
|
HWEI-FANG TIEN; Tsay W.; Tang J.-L.; Chou W.-C.; Yao M.; Huang S.-Y.; Chen C.-Y.; Sheng W.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-04T12:12:34Z |
An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
|
HWEI-FANG TIEN; Chen Y.; Chuang E.Y.; Kuo Y.-Y.; Tseng M.-H.; Hou H.-A.; Chou W.-C.; Chiu Y.-C.; Chuang M.-K. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients
|
Chuang M.-K.; Chiu Y.-C.; Chou W.-C.; Hou H.-A.; Chuang E.Y.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Chen Y.-C.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:33Z |
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
|
Kitamura T.; HWEI-FANG TIEN; Abdel-Wahab O.; Inaba T.; Harada H.; Harada Y.; Hayashi Y.; Inoue D.; Kitaura J.; Matsui H.; Hou H.-A.; Chou W.-C.; Nagamachi A.; Kawabata K.C.; Togami K.; Nagase R.; Horikawa S.; Saika M.; Micol J.-B. |
| 臺大學術典藏 |
2021-01-04T12:12:32Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
HWEI-FANG TIEN; Tsay W.; Sheng W.-H.; Tang J.-L.; Yao M.; Chou W.-C.; Cheng A.; Huang S.-Y.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:31Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Lin H.-H.; Huang S.-Y.; Tsay W.; Lu H.-Y.; Ko B.-S.; Hsu S.-C.; Chou W.-C.; Chou S.-C.; Hou H.-A.; Wu S.-J.; Yao M.; Tang J.-L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:30Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Kuo Y.-Y.; Hou H.-A.; Liu C.-Y.; Huang S.Y.; Li C.-C.; Yao M.; Liu C.-W.; Tang J.-L.; Chiang Y.-C.; Liu M.-C.; Tseng M.-H.; Lin L.-I.; Lin C.-C.; Tsai C.-H.; Chou W.-C.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:29Z |
Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia
|
Chiu Y.-C.; Tsai M.-H.; Chou W.-C.; Liu Y.-C.; Kuo Y.-Y.; Hou H.-A.; Lu T.-P.; Lai L.-C.; Chen Y.; HWEI-FANG TIEN; Chuang E.Y. |
| 臺大學術典藏 |
2021-01-04T12:12:28Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tang J.-L.; Liu C.-Y.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Wu S.-J.; Lin C.-T.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y. |
| 臺大學術典藏 |
2021-01-04T12:12:26Z |
Aurora A and NF-κB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-interacting protein TIFA
|
Teng C.-L.J.; Chou W.-C.; Wu T.-J.; Hou H.-A.; Wu P.-Y.; Wei T.-Y.W.; Lin C.-R.; Chen J.-M.M.; Lin T.-Y.; Su H.-C.; Huang C.-C.F.; Yu C.-T.R.; Hsu S.-L.; HWEI-FANG TIEN; Tsai M.-D. |
| 臺大學術典藏 |
2021-01-04T12:12:24Z |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
|
Chiang Y.-C.; Tseng M.-H.; Kuo Y.-Y.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tsai C.-H.; Lin T.-Y.; Hou H.-A.; Lu J.-W.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:23Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Ko B.-S.; Huang S.-Y.; Li C.-C.; Tang J.-L.; Yao M.; Chen C.-Y.; Chou W.-C.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Kuo Y.-Y.; Wu S.-J.; Hou H.-A.; Tsai C.-H.; Hsu S.-C.; Lin C.-T.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:21Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; HWEI-FANG TIEN; Chou W.-C.; Yao M.; Huang S.-Y.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Wu S.-J.; Tsai C.-H.; Huang T.-C.; Lin C.-T.; Liu J.-H.; Yao M.; Huang H.-H.; Hou H.-A.; Hsu S.-C.; Weng P.-F.; Li C.-C.; Li J.-L.; Ko B.-S.; Wang Y.-F.; Huang S.-Y.; Chou W.-C.; HWEI-FANG TIEN; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-04T12:12:19Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Chiu Y.-C.; Kuo Y.-Y.; Tien F.-M.; Tang J.-L.; Yao C.-Y.; Tsai C.-H.; HWEI-FANG TIEN; Hou H.-A.; Chen C.-Y.; Lin L.-I.; Chou W.-C.; Yao M.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Lin C.-C.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:18Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Tseng M.-H.; HWEI-FANG TIEN; Huang S.-Y.; Chen C.-Y.; Hsu S.-C.; Wu S.-J.; Tsay W.; Yao M.; Li C.-C.; Tang J.-L.; Lin C.-T.; Ko B.-S.; Chou W.-C.; Hou H.-A.; Huang H.-H.; Chen F.-Y.; Chen R.-H. |
| 臺大學術典藏 |
2021-01-04T12:12:17Z |
The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes
|
Hung S.-Y.; Lin C.-C.; Hsu C.-L.; Yao C.-Y.; Wang Y.-H.; Tsai C.-H.; Hou H.-A.; Chou W.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:17Z |
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
|
Wang Y.-H.; Lin C.-C.; Hsu C.-L.; Hung S.-Y.; Yao C.-Y.; Lee S.-H.; Tsai C.-H.; Hou H.-A.; Chou W.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Lin C.-C.; Wang Y.-W.; Tsai C.-H.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:16Z |
A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
|
Wang Y.-H.; Lin C.-C.; Yao C.-Y.; Hsu C.-L.; Hou H.-A.; Tsai C.-H.; Chou W.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:15Z |
Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice
|
Lin C.-C.; Yao C.-Y.; Hsu Y.-C.; Hou H.-A.; Yuan C.-T.; Li Y.-H.; Kao C.-J.; Chuang P.-H.; Chiu Y.-C.; Chen Y.; Chou W.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-04T12:12:14Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Yao M.; Kuo Y.-Y.; Hou H.-A.; Huang T.-C.; Wu S.-J.; Tsai C.-H.; Wang Y.-H.; Lin C.-C.; Lee S.-H.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; HWEI-FANG TIEN |
| 國立成功大學 |
2021 |
High expression of kr�ppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, S.-L.;Shan, Y.-S.;Hsiao, C.-F.;Liu, T.-W.;Chen, J.-S.;Ho, C.-L.;Chou, W.-C.;Hsieh, R.-K.;Chen, L.-T.;Ch'ang, H.-J. |
